Detalles de la búsqueda
1.
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.
Acta Oncol
; 61(6): 705-713, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35435129
2.
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
Oncologist
; 25(6): e936-e945, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243668
3.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32735386
4.
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer.
Invest New Drugs
; 36(2): 278-287, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29250742
5.
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Ann Intern Med
; 167(5): 341-350, 2017 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28785760
6.
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
Lancet Oncol
; 18(11): 1532-1542, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29033099
7.
Addressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins.
Future Oncol
; 13(4): 369-379, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27712093
8.
A Large Number of Fresh Samples and a Wide Range of Total Prostate-Specific Antigen (tPSA) Concentrations Is Important to Detect Differences in PSA Methods.
Clin Chem
; 67(8): 1155-1157, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34352086
9.
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCIâ¯9041).
Invest New Drugs
; 34(1): 104-11, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686201
10.
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.
Lancet Oncol
; 16(2): 208-20, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25596660
11.
Evolution of Cancer Care in Response to the COVID-19 Pandemic.
Oncologist
; 25(9): e1426-e1427, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536024
12.
13.
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
Lancet Oncol
; 15(11): 1263-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25242048
14.
A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors.
Invest New Drugs
; 32(6): 1226-35, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25037863
15.
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).
Invest New Drugs
; 32(2): 243-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23645447
16.
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.
Invest New Drugs
; 32(5): 1005-16, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24788563
17.
Nivolumab in Squamous Cell Carcinomas of the Head and Neck (SCCHN): A Real-world Outcome Study in Ontario, Canada.
J Immunother
; 47(4): 123-127, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38230590
18.
177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice.
Curr Oncol
; 31(3): 1400-1415, 2024 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534939
19.
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.
Clin Cancer Res
; 30(1): 63-73, 2024 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861407
20.
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.
Can Urol Assoc J
; 18(4): E127-E137, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381937